Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid adjuvant therapy for malignant breast phyllodes tumor
ChiCTR1800017822Phase 2Completed
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of zoledronic acid in malignant phyllodes tumor (MPT), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: 3-year disease-free survival. Started Oct 2018; status: completed.
02
Drugs
zoledronic acid
03
Conditions
malignant phyllodes tumor (MPT)
Beyond the preview
Go deeper on ChiCTR1800017822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017822.